Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4072)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 27, 2023 (publication date) through Jun 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen L. From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus. World J Hepatol 2023; 15(12): 1253-1257 [PMID: 38223415 DOI: 10.4254/wjh.v15.i12.1253] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v15/i12/1253.htm |
| Number | Citing Articles |
| 1 |
Weixin Wang, Xin Gao, Wentong Niu, Jinping Yin, Kan He. Targeting Metabolism: Innovative Therapies for MASLD Unveiled. International Journal of Molecular Sciences 2025; 26(9): 4077 doi: 10.3390/ijms26094077
|
| 2 |
Ehsan Amini-Salehi, Negin Letafatkar, Naeim Norouzi, Farahnaz Joukar, Arman Habibi, Mona Javid, Nazila Sattari, Mehrdad Khorasani, Ali Farahmand, Shervin Tavakoli, Behnaz Masoumzadeh, Elaheh Abbaspour, Sahand Karimzad, Amir Ghadiri, Gautam Maddineni, Mohammad Javad Khosousi, Niloofar Faraji, Mohammad-Hossein Keivanlou, Abinash Mahapatro, Mohamad Amin Khajavi Gaskarei, Paria Okhovat, Ali Bahrampourian, Maryam Sadat Aleali, Arian Mirdamadi, Narges Eslami, Mohamadreza Javid, Naz Javaheri, Shrinidhi Vilas Pra, Arash Bakhsi, Mohammad Shafipour, Azin Vakilpour, Malek Moein Ansar, Sai Guatham Kanagala, Mohamad Hashemi, Arezoo Ghazalgoo, Masoumeh Kheirandish, Parham Porteghali, Forough Heidarzad, Taraneh Zeinali, Fariborz Mansour Ghanaei, Soheil Hassanipour, Michael.T Ulrich, Joshua E. Melson, Dhruvan Patel, Sandeep Samethadka Nayak. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Archives of Medical Research 2024; 55(6): 103043 doi: 10.1016/j.arcmed.2024.103043
|
| 3 |
Georgiana-Diana Cazac, Bogdan-Mircea Mihai, Gabriela Ștefănescu, Georgiana-Emmanuela Gîlcă-Blanariu, Cătălina Mihai, Elena-Daniela Grigorescu, Alina Onofriescu, Cristina-Mihaela Lăcătușu. Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients 2024; 16(13): 2008 doi: 10.3390/nu16132008
|
| 4 |
Salvatore Corrao, Luigi Calvo, Walter Granà, Salvatore Scibetta, Luigi Mirarchi, Simona Amodeo, Fabio Falcone, Christiano Argano. Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(2): 103702 doi: 10.1016/j.numecd.2024.07.019
|
| 5 |
Anil Chandra Anand, Dibyalochan Praharaj. MASLD or MAFLD: fatty liver by any name will pose the same challenge. Metabolism and Target Organ Damage 2025; 5(2) doi: 10.20517/mtod.2025.18
|
| 6 |
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Govind Pradeep, Aswathy R. Devan, Gautam Sethi, Lekshmi R. Nath. Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: Therapeutic insights and strategies. Drug Discovery Today 2024; 29(8): 104064 doi: 10.1016/j.drudis.2024.104064
|
| 7 |
Ilaria Milani, Michela Codini, Gloria Guarisco, Marianna Chinucci, Chiara Gaita, Frida Leonetti, Danila Capoccia. Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target. International Journal of Molecular Sciences 2024; 25(19): 10795 doi: 10.3390/ijms251910795
|